1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Single Person: new trials by email Literature Review of Single Person trials Research Report on Single Person
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors PD-1/PD-L1 inhibitors (alone or in combination with chemotherapy), SBRT - NSCLC Stage IV | Phase 2 | Unknown | Fudan University | 59 | 2021-01-01 | 2025-04-30 |
Carcinoma, Non-Small-Cell Lung (1)
Fudan University (1)
China (1)
Zhengfei Zhu, MD (1)